Other studies have also shown AnxA1 to exert its effects via the FPR2/ALX/p38 mitogen-activated protein kinase (“MAPK”)/COX-2 pathway in an experimental model of intracerebral haemorrhage, although other MAPKs may also be involved [65]. Here, MAPK14 is linked to intracerebral hemorrhage.